ATE101200T1 - Impfstoffe gegen menschliche respiratorische viren. - Google Patents

Impfstoffe gegen menschliche respiratorische viren.

Info

Publication number
ATE101200T1
ATE101200T1 AT87900757T AT87900757T ATE101200T1 AT E101200 T1 ATE101200 T1 AT E101200T1 AT 87900757 T AT87900757 T AT 87900757T AT 87900757 T AT87900757 T AT 87900757T AT E101200 T1 ATE101200 T1 AT E101200T1
Authority
AT
Austria
Prior art keywords
against human
proteins
human respiratory
vaccines
vaccines against
Prior art date
Application number
AT87900757T
Other languages
English (en)
Inventor
Gail W Wertz
Peter L Collins
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Application granted granted Critical
Publication of ATE101200T1 publication Critical patent/ATE101200T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT87900757T 1986-01-14 1987-07-21 Impfstoffe gegen menschliche respiratorische viren. ATE101200T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81874086A 1986-01-14 1986-01-14
PCT/US1986/002756 WO1987004185A1 (en) 1986-01-14 1986-12-23 Vaccines for human respiratory virus
EP87900757A EP0290446B1 (de) 1986-01-14 1987-07-21 Impfstoffe gegen menschliche respiratorische viren

Publications (1)

Publication Number Publication Date
ATE101200T1 true ATE101200T1 (de) 1994-02-15

Family

ID=25226293

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87900757T ATE101200T1 (de) 1986-01-14 1987-07-21 Impfstoffe gegen menschliche respiratorische viren.

Country Status (7)

Country Link
EP (1) EP0290446B1 (de)
JP (2) JPH01501357A (de)
AT (1) ATE101200T1 (de)
AU (1) AU605476B2 (de)
DE (1) DE3689622T2 (de)
HK (1) HK51597A (de)
WO (1) WO1987004185A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223254A (en) * 1987-09-29 1993-06-29 Praxis Biologics, Inc. Respiratory syncytial virus: vaccines
US5639853A (en) * 1987-09-29 1997-06-17 Praxis Biologics, Inc. Respiratory syncytial virus vaccines
WO1989004835A1 (en) * 1987-11-20 1989-06-01 The Upjohn Company HUMAN RESPIRATORY SYNCYTIALVIRUS VACCINE DERIVED FROM THE 1A (9.5 kD) PROTEIN
AU617739B2 (en) * 1987-12-23 1991-12-05 Pharmacia & Upjohn Company Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus
IE912586A1 (en) * 1990-07-24 1992-01-29 Uab Research Foundation Bovine respiratory syncytial virus vaccines
US6730305B1 (en) 2000-05-08 2004-05-04 The Uab Research Foundation Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins
TW275632B (de) * 1992-04-21 1996-05-11 American Cyanamid Co
FR2726577B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament
FR2726576B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Production de peptides analogues de peptides hydrophobes, peptide recombinant, sequence d'adn correspondante
DE69720024D1 (de) * 1996-07-12 2003-04-24 Aventis Pasteur Immunisierungsverfahren in zwei schritten gegen pyramyxoviridae-viren unter verwendung abgeschwächter viraler stämme und preparation von proteinuntereinheiten
US6020182A (en) * 1996-07-12 2000-02-01 Connaught Laboratories Limited Subunit respiratory syncytial virus vaccine preparation
US20020136739A1 (en) * 1996-07-12 2002-09-26 Cates George A. Subunit respiratory syncytial virus preparation
US6180398B1 (en) * 1996-07-12 2001-01-30 Virogeneitics Corporation Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation
AU2001278337A1 (en) * 2000-07-31 2002-02-13 Aventis Pasteur Limited Respiratory syncytial virus vaccine
FR2827605B1 (fr) 2001-07-20 2004-07-16 Pf Medicament Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin
PT2667892T (pt) 2011-01-26 2019-06-07 Glaxosmithkline Biologicals Sa Regime de imunização contra o vsr
EP3630173A1 (de) * 2017-05-29 2020-04-08 The United States of America, as represented by the Secretary, Department of Health and Human Services Rekombinantes chimäres bovines/humanes parainfluenzavirus 3, das rsv g exprimiert, und seine verwendung

Also Published As

Publication number Publication date
WO1987004185A1 (en) 1987-07-16
AU6941287A (en) 1987-07-28
DE3689622D1 (de) 1994-03-17
EP0290446A1 (de) 1988-11-17
AU605476B2 (en) 1991-01-17
JPH08173171A (ja) 1996-07-09
EP0290446B1 (de) 1994-02-02
JPH01501357A (ja) 1989-05-18
DE3689622T2 (de) 1994-06-16
HK51597A (en) 1997-04-25

Similar Documents

Publication Publication Date Title
FI102382B1 (fi) Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykoproteiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoproteiineja varten
ATE101200T1 (de) Impfstoffe gegen menschliche respiratorische viren.
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
NO20013701L (no) HER-2/neu-fusjonsproteiner
CY1115749T1 (el) Κυκλοϊος χοιρων, νουκλεϊνικα οξεα, πολυπεπτιδια και εμβολια
BR1101088A (pt) Proteìna g do vìrus sincicial respiratório não glicosilada isolada e substancialmente pura
NO975730L (no) Metode for ökning av beskyttende immunresponser
KR950700756A (ko) 바이러스성 질병 및 악성종양의 치료를 위한, 생바이러스(live virus)를 함유하는 백신(VACCINE CONTAINING LIVE VIRUSES FOR THERAPY OF VIRAL DISEASES AND MALIGNANCIES)
EA199800746A1 (ru) Способ генерации противовирусного иммунного ответа у человека или животного
ES2038689T3 (es) Procedimiento de cultivo del virus de la rinotraqueitis infecciosa de la pava, y vacuna preparada a partir del virus asi obtenido.
KR890700030A (ko) 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법
ATE82985T1 (de) Strukturelles phosphoprotein (pp 150) des menschlichen cytomegalovirus, seine herstellung und verwendung.
DE3585578D1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
AU3379693A (en) Vaccines and diagnostic assays for haemophilus influenzae
DE69633919D1 (de) Mehrzweckvakzine gegen umhüllte viren
Allen et al. Proteins of equine herpesvirus type 3 I. Polypeptides of the purified virion
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
SE8700466D0 (sv) Vaccines against melanoma
ATE126702T1 (de) Verfahren zur herstellung von impfstoffen gegen rna-virus.
NO931821L (no) Hepatitt b vaksinepreparat som omfatter et gallesyresalt
RU93005036A (ru) Способ лечения вируса иммунодефицита человека
TH63069A (th) โคลนก่อการติดเชื้อ

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time